These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Author: Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Journal: Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863. Abstract: PURPOSE: To investigate whether interleukin-6 (IL-6) or vascular endothelial growth factor (VEGF) is related to diabetic macular edema (DME) in subjects without posterior vitreous detachment (PVD). DESIGN: Retrospective case-control study. PARTICIPANTS: Twenty-six subjects who had DME without PVD and 12 subjects who had nondiabetic ocular disease (the control group). METHODS: Vitreous fluid samples were obtained at vitreoretinal surgery, and the IL-6 and VEGF levels in vitreous fluid and plasma were measured by enzyme-linked immunosorbent assay. MAIN OUTCOME MEASURES: Vitreous levels of IL-6 and VEGF in DME subjects without PVD. RESULTS: The vitreous levels of both IL-6 and VEGF were significantly higher in the subjects with DME than in control subjects (P<0.0001 and P<0.0001, respectively). The vitreous level of IL-6 was significantly correlated with that of VEGF (P<0.0001). Vitreous levels of both IL-6 and VEGF were significantly higher in subjects with hyperfluorescent DME than in those with minimally fluorescent DME (P = 0.0008 and P = 0.0038, respectively). CONCLUSIONS: We found that the levels of both IL-6 and VEGF were elevated in the vitreous fluid of subjects with hyperfluorescent DME. Our results suggest that IL-6 and VEGF may promote an increase of vascular permeability in DME subjects without PVD. Interleukin-6 may possibly induce an increase of vascular permeability through a paracrine effect on VEGF in these subjects.[Abstract] [Full Text] [Related] [New Search]